By expenditures
| Name | Title | Type |
|---|---|---|
| Kevin Kerswick | Partner | Auditee |
| Chris Street | CHIEF FINANCIAL OFFICER | Auditee |
| Miranda Wendlandt | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 336751 | 2024 | 2025-01-09 | Crowe LLP | $46.61M |
| 17218 | 2022 | 2023-03-21 | Cliftonlarsonallen LLP | $29.92M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 336751 | 2024 | 2025-01-09 | 1094835 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 1094834 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 1094833 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 1094832 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 1094831 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 1094830 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 1094829 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 1094828 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 1094827 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 1094826 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 1094825 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 1094824 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 518393 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 518392 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 518391 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 518390 | 2024-003 | Material Weakness | - | L |
| 336751 | 2024 | 2025-01-09 | 518389 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 518388 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 518387 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 518386 | 2024-002 | Significant Deficiency | - | I |
| 336751 | 2024 | 2025-01-09 | 518385 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 518384 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 518383 | 2024-001 | Material Weakness | - | E |
| 336751 | 2024 | 2025-01-09 | 518382 | 2024-001 | Material Weakness | - | E |